S

Swiftpharma (Private limited company)

BE 0781.598.284 Active ●Thor Park 8027, 3600 Genk

Swiftpharma is a Belgian company registered with the Crossroads Bank for Enterprises under enterprise number 0781.598.284. It was founded on 04-02-2022. Its registered office is in Genk. Its main activity is: Wholesale trade. Its annual accounts for 2025 report equity of € 834 755 and a loss of € 1 750 880. These accounts report 12.3 full-time equivalents. Addrly gives it a financial health grade of B, on a scale from A (safest) to E (most at risk). It filed its annual accounts within the legal deadline for each of its last 3 financial years.

Information last updated on 07-10-2026.

Company information

Status
Active
Enterprise number
BE 0781.598.284
VAT registered
Yes
Founded
04-02-2022
Latest accounts
2025
Employees
12.3 FTE
Region
Flanders
Establishments
1
Filing record
On time 3 of 3 years
Peppol e-invoicing
Registered
Registered office
Thor Park 8027, 3600 Genk
Main activity
Wholesale trade
NACE activities
46460 Commerce de gros de produits pharmaceutiques et médicaux
21100 Fabrication de produits pharmaceutiques de base
72109 Recherche-développement en autres sciences physiques et naturelles
73200 Études de marché et sondages

Key figures of Swiftpharma

202520242023
Profit / loss
iWhat the period earned after taxes. A negative amount is a loss.
€ -1 750 880+7 %€ -1 883 926€ 57 060
Equity
iWhat belongs to the shareholders: capital contributed, reserves and profits kept in the company.
€ 834 755-68 %€ 2 585 634+4 241 %€ 59 560
Total assets
iEverything the company owns. Equal to total equity and liabilities, which says how it is financed.
€ 4 898 030+1 %€ 4 832 664+329 %€ 1 127 021
Gross margin
iSales and other operating income, minus purchases of goods and services. What is left to pay the staff and everything else.
€ -22 099+98 %€ -1 382 412€ 331 174
Employees (FTE)
iAverage number of workers over the period, in full-time equivalents.
12.3+339 %2.8+180 %1

Financial estimate

Financial health grade B, on a scale from A (safest) to E (most at risk)
Health barometer
The failure probability and the indicators behind this grade are visible with a free account.
Create a free account
Illustrative preview
Detected events
Appointments, capital, registered office, proceedings, extracted from the official acts.
Create a free account
Illustrative preview
Directors & mandates
6 mandates on record in the annual accounts. 3 of them started since 2024.
Create a free account

Similar companies

Other companies in the same activity in Genk.

CompanyTown
Foresco BE 3600 Genk
CONSTRUCT PROTECT ENGINEERING 3600 Genk
H. ESSERS TRANSPORT COMPANY 3600 Genk
SPRONKEN ORTHOPEDIE 3600 Genk
KEVA 3600 Genk
DI NITTO GENK 3600 Genk
A&M QUC 3600 Genk
STEVENS RECYCLING 3600 Genk
Looking for more information about Swiftpharma?
The free plan gives you 20 complete company dossiers every month, no card required: health barometer, directors, company links and detected events.
Create a free account

Frequently asked questions

Is Swiftpharma still active? Yes. The Crossroads Bank for Enterprises lists Swiftpharma as active.

What is the VAT number of Swiftpharma? The VAT number of Swiftpharma is BE 0781.598.284.

When was Swiftpharma founded? Swiftpharma was founded on 04-02-2022.

What is the address of Swiftpharma? The current registered office of Swiftpharma is Thor Park 8027, 3600 Genk.

When did Swiftpharma last file annual accounts? The latest annual accounts of Swiftpharma were filed on 27-04-2026.

Does Swiftpharma file its annual accounts on time? Yes. Swiftpharma filed its annual accounts within the legal deadline for each of its last 3 financial years.

How many employees does Swiftpharma have? Swiftpharma employs 12.3 full-time equivalents according to its most recent annual accounts.

Is Swiftpharma financially healthy? Addrly gives Swiftpharma a financial health grade of B, on a scale from A (safest) to E (most at risk). The failure probability and the indicators behind it are visible with a free account.

Is Swiftpharma profitable? The annual accounts of Swiftpharma for 2025 show a loss of € 1 750 880.

What is the equity of Swiftpharma? The equity of Swiftpharma was € 834 755 at the close of the 2025 financial year.

Who are the directors of Swiftpharma? The annual accounts of Swiftpharma record 6 mandates. The names, roles and dates are visible with a free account.

Can Swiftpharma receive Peppol e-invoices? Yes. Swiftpharma is registered on the Peppol network and can receive structured electronic invoices.

What does Swiftpharma do? The main activity of Swiftpharma is: Wholesale trade.

Sources

How Addrly builds and refreshes this data